...
首页> 外文期刊>Neuropsychiatric Disease and Treatment >Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients
【24h】

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients

机译:571名严重抑郁症门诊患者中医学上无法解释的疼痛性躯体症状的患病率和诊断分布

获取原文

摘要

Objective: To assess the prevalence and distribution of medically unexplained painful somatic symptoms (PSSs) versus nonpainful somatic symptoms (NPSSs) in patients diagnosed with major depressive episode (MDE).Method: A total of 571 outpatients diagnosed with MDE according to DSM-IV-TR criteria were consecutively enrolled into a cross-sectional, multicentric, observational study over a period of 7 months. Subjects were evaluated by means of the ad hoc validated 30-item Somatic Symptoms Checklist (SSCL-30) and Zung's questionnaires for depression and anxiety. The 32-item Hypomania Checklist (HCL-32) was also administered in order to explore any eventual association of PSSs or NPSSs with sub-threshold (DSM-IV-TR [Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision] not recognized) bipolar disorder (BD).Results: In our sample, just 183 patients (32%) did not report painful somatic symptoms (NPSSs). Of these, 90 patients (15.76%) had no somatic symptoms at all. The remaining 388 (68%) had at least one PSS being subdivided as follows: 248 (43%) had one or two PSSs, while 140 (25%) experienced two or more. Patients with at least one PSS also reported a greater number of nonpainful somatic symptoms than NPSS. Bipolar patients (associated with higher HCL-32 scores) were less represented across PSS cases than NPSS subjects. Conversely, females were more prone to having a higher number of total somatic symptoms (and bipolar features).Conclusion: PSSs are common in patients with MDE, especially among those patients reporting fewer somatic symptoms in general as opposed to those patients who exhibit more somatic symptoms (both PSSs and NPSSs) with lower relative number of PSSs. A major therapeutic implication is that antidepressant monotherapy could be used with more confidence in unexplained PSS patients than in NPSS patients because of the latter group's lower frequency of (sub)-threshold bipolar features.
机译:目的:评估诊断为重度抑郁发作(MDE)的患者无法解释的疼痛性躯体症状(PSS)与非疼痛性躯体症状(NPSS)的患病率和分布。方法:根据DSM-IV,共有571名门诊患者被诊断为MDE -TR标准连续7个月参加了一项横断面,多中心,观察性研究。通过临时验证的30项躯体症状检查表(SSCL-30)和Zung的抑郁症和焦虑症问卷对受试者进行评估。为了探究PSS或NPSS与亚阈值之间的任何最终联系,还管理了32个项的低躁狂检查表(HCL-32)(DSM-IV-TR [精神疾病诊断和统计手册,第四版,文本修订]结果:在我们的样本中,只有183例患者(32%)没有报告痛苦的躯体症状(NPSS)。其中,有90名患者(15.76%)完全没有躯体症状。其余的388个(68%)至少细分了一个PSS,如下:248个(43%)拥有一个或两个PSS,而140个(25%)经历了两个或更多。患有至少一种PSS的患者还报告了比NPSS更多的非疼痛性躯体症状。与NPSS受试者相比,PSS病例中双相情感障碍患者(与HCL-32评分更高相关)的代表较少。相反,女性更容易出现更多的总体躯体症状(和双相性特征)。结论:PSS在MDE患者中很常见,尤其是那些体细胞症状较少的患者,而不是表现出更多躯体症状的患者PSS相对数量较低的症状(PSS和NPSS)。一个主要的治疗意义是,对于无法解释的PSS患者,抗抑郁药物单药疗法比NPSS患者更有信心,因为后者的(亚)阈值双极特征频率较低。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号